Cargando…
Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges
Myeloproliferative neoplasms (MPNs) are a group of clonal hematologic malignancies that include polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). MPNs are characterized by activating mutations in the JAK/STAT pathway and an increased risk of transformation to an aggress...
Autores principales: | Ajufo, Helen O., Waksal, Julian A., Mascarenhas, John O., Rampal, Raajit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410182/ https://www.ncbi.nlm.nih.gov/pubmed/37564898 http://dx.doi.org/10.1177/20406207231177282 |
Ejemplares similares
-
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
por: Wang, Xiaoli, et al.
Publicado: (2022) -
Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019) -
Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm
por: Tefferi, Ayalew, et al.
Publicado: (2023) -
Novel therapeutics in myeloproliferative neoplasms
por: Venugopal, Sangeetha, et al.
Publicado: (2020) -
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival
por: Abdelmagid, Maymona G., et al.
Publicado: (2023)